Research and experimental development on natural sciences and engineering
BIOSERGEN AS
Revenue 2024
NOK 75,000
Operating profit
NOK −10.0m
Equity
NOK 5.4m
Incorporated
2004
Share capital
NOK 4.3m
Key figures · 2024
Current ratio
0.42
Equity ratio
24.7%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -13350.6% | |
| Net margin (%%) | -13915.0% | |
| Return on assets (%%) | -46.0% | |
| Likviditet | ||
| Current ratio | 0.42 | |
| Working capital | −9.5m | |
| Soliditet | ||
| Equity ratio (%%) | 24.7% | |
| Debt-to-equity ratio | 3.04 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.